Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
Clinical trial NCT04932291 · COMPLETED
Trial details
- NCT number
- NCT04932291
- Sponsor
- Oryzon Genomics S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2023-10-30
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.